Science and Technology News and Videos
Though Medicare could stand to vastly increase access for a wider proportion of people, not every Medicare member will qualify. Per the report, only those with a history of heart disease, and who plan to use the drug to prevent heart attacks and strokes, could have their Wegovy treatments covered by insurance.
In other words, the drug won't be covered by insurance if it's being used solely for the purpose of weight loss. Wegovy, pharmaceutical company Novo Nordisk's brand name for the drug semaglutide, was approved by the Food and Drug Administration in 2021. It assists in weight loss by reducing appetite with a hormone in the gut, and according to a recent study, it also Medicare is a federal health insurance program for people over 65, and younger people with disabilities in the US. Until now, US law has prevented the program's Part D drug-benefit plans from paying for obesity treatments. Part D plan holders tend to be senior citizens, but the program is technically open to all who qualify for Medicare. Many Part D plans already pay for drugs with the same main ingredient as Wegovy called semaglutide, including Ozempic and Mounjaro — but only for treating diabetes.But given the latest news — which still pivots on a green light from the federal government — the pressure on those insurers could soon rise considerably.without insurance, which makes them unaffordable to many. Experts, however, are predicting prices will fall as competing obesity drug makers enter the market. Now that Medicare will start covering Wegovy, the drug will open up to price negotiations under president Joe Biden's Inflation Reduction Act,With help from insurers, the drug could help millions fight heart disease, and eventually weight loss as well, according to experts. "We could see Medicare patients with both conditions get coverage of this drug for its heart health benefits," deputy director of the Medicare policy program Juliette Cubanski. "That’s potentially a big deal given the large demand for this drug even in the absence of many insurers covering it."Subscribe to our daily newsletter to keep in touch with the subjects shaping our future. I understand and agree that registration on or use of this site constitutes agreement to its User Agreement and Privacy Policy
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The View co-host predicts voters will ‘start paying attention’ once Trump wins 2024 GOP nominationThe comments from The View come as former President Donald Trump is predicted by many to win the Republican Party's 2024 nomination for president.
Read more »
Patients, Advocates Push Biden to 'Reclaim Medicare' From Privatized Medicare AdvantageJake Johnson is a senior editor and staff writer for Common Dreams.
Read more »
A Soggy start to Sunny skies, a Chilly, Breezy start to SpringA Soggy start to Sunny skies, a Chilly, Breezy start to Spring
Read more »
Donald Trump has been all over the map on Social Security and MedicareSahil Kapur is a senior national political reporter for NBC News.
Read more »
Austin spring festival and event guide: Big events happening in March, April and May 2024Music wristbands start at $149, and Film & TV wristbands start at $120.
Read more »
Medicare can pay for obesity drugs like Wegovy in certain heart patientsCertain Medicare patients may get help paying for the popular weight-loss drug Wegovy, as long as they also have heart disease. The Centers for Medicare & Medicaid Services issued new gudiance that says Medicare Part D drug benefit plans can cover anti-obesity drugs as long as they're approved for an additional use.
Read more »